Category Medicine and Healthcare
Press Release
Telomir Pharmaceuticals Secures $3 Million at a Premium in Straight Equity Sale Involving No Warrants to Advance Rare Disease IND
Investment from largest shareholder strengthens balance sheet, signals insider conviction, and funds Telomir-1's upcoming IND submission for a rare disease indication Read More
Press Release
Regenerative Medical Technologies Group Increases Q1 2025 Sales By 67% Over Q1 2024 and Achieves Operating Profit for the Quarter of $134,000
Regenerative Medical Technologies Group, Inc. $RMTG, a regenerative medicine company, is pleased to announce that sales for its first quarter of 2025 surpassed $1.35M and achieved operational profits of $134,000 for the quarter. Read More
Press Release
First Patient Randomized in Jaguar Health's Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID)
As announced, initial proof-of-concept (POC) results from distinct ongoing investigator-initiated trial (IIT) in Abu Dhabi show crofelemer reduced total parenteral support in a pediatric MVID patient with intestinal failure by up to 27%; per the IIT protocol, patient was taken off crofelemer after 12 weeks of treatment for a period of 30 days, but was restarted on daily crofelemer treatment after just 8 days, as patient's symptoms were worsening Additional POC IIT results expected throughout 2025 for MVID; results from company's MVID Phase 2 study expected with completion of treatment in H2 2026 Ground-breaking results in single-digit number of MVID patients could potentially lead to expedited approval in the EU through PRIME and to Breakthrough Therapy designation in the US Read More
Press Release
ZetrOZ Systems' sam(R) Wearable Ultrasound Helps Osteoarthritis Patients Return to Regular Activities
The sam® sustained acoustic medicine device can help millions of people suffering from knee osteoarthritis to find relief, without invasive surgery or potentially addictive painkiller medications. Read More
Press Release
Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Trial marks key milestone in driving pipeline progress Phase 1 trial scheduled for completion mid-June 2025 Topline data from High-Dose Aspirin Trail anticipated early in 3Q with the potential to support an accelerated approval, subject to FDA feedback Read More
Press Release
Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis
Key Regulatory Milestone Provides Clear Development Roadmap to Registration for MOTYS Initiation of Phase 3 Program Remains on Schedule to Begin in Q3 2025 Read More
Press Release
Interactive Strength Inc. (Nasdaq:TRNR) Reiterates $75M Guidance, Expected Profitability in Q4 on Adjusted EBITDA Basis Due to Pending Sportstech, Wattbike Deals
Company Updates Investor Presentation to Reflect Strong Q1 Earnings, More than $20M in Pro Forma Revenue and 15% Increase in 2025 Pro Forma Revenue Guidance Read More
Press Release
Why Are DEA’s Prevoznik and Strait Lecturing the World on Drug Policy While Undermining U.S. Marijuana Law?
The appearance of Thomas Prevoznik and Matthew Strait as thought leaders in global drug policy is more than just tone-deaf-it's dangerous. It validates a failed regulatory approach that punishes innovation, undermines public health, and sidelines scientific progress for political convenience Read More
Press Release
AGFA HealthCare Recognized for Proactive Partnerships and Communication in 2025 in the KLAS PACS Market Report - Earning a Top Performer Position for PACS Performance Across All Site Sizes
AGFA HealthCare earns top-tier recognition for consistently delivering high-value imaging management solutions and services to healthcare organizations of all sizes. Read More
Press Release
CrossTx Inc. Selected by EverCare Mobile Health to Power Care Management Platform for Long-Term Mental Health Innovation Across Idaho
CrossTx Inc., a national leader in Medicare care management solutions, is proud to announce a strategic partnership with EverCare Mobile Health, Idaho's fast-growing mobile mental healthcare provider serving long-term care facilities across the region. Read More
Press Release
Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy
Early results show steroid-free remission, opening pathway into $13B global pet dental health market VELDONA delivers consistent anti-inflammatory effects, strengthening Ainos' positioning in companion animal immunotherapy Read More
Press Release
Interactive Strength Inc. (Nasdaq: TRNR) Reports First Quarter 2025 Results, Increases 2025 Pro Forma Revenue Guidance to more than $75M
Company reports quarterly revenue of $1.4 million; net loss and earnings per diluted Share of $6.6 million and $1.74 Quarterly adjusted EBITDA loss of $2.5 million reflects 29% YOY improvement Stockholders' equity was $13.8 million at quarter end Increases 2025 pro forma revenue guidance to more than $75 million based on strong first quarter across TRNR, Sportstech and Wattbike Read More
Press Release
DEA Marijuana Hypocrisy Exposed: MMJ Legal Drug Blocked While Cartels Thrive in Marijuana Legal States
"The DEA is creating a regulatory paradox where science is stifled and illegal activity is tolerated. Thomas Prevoznik, one unelected bureaucrat should not have the power to derail federally authorized drug development," said Duane Boise, CEO of MMJ International Holdings. Read More
Press Release
